Acetazolamide reduces exercise capacity following a 5-day ascent to 4559 m in a randomised study

OBJECTIVE: To assess whether acetazolamide (Az), used prophylactically for acute mountain sickness (AMS), alters exercise capacity at high altitude. METHODS: Az (500 mg daily) or placebo was administered to 20 healthy adults (aged 36±20 years, range 21–77), who were paired for age, sex, AMS suscepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradwell, Arthur R, Ashdown, Kimberley, Rue, Carla, Delamere, John, Thomas, Owen D, Lucas, Samuel J E, Wright, Alex D, Harris, Stephen J, Myers, Stephen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783038/
https://www.ncbi.nlm.nih.gov/pubmed/29387446
http://dx.doi.org/10.1136/bmjsem-2017-000302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783038/
https://www.ncbi.nlm.nih.gov/pubmed/29387446
http://dx.doi.org/10.1136/bmjsem-2017-000302

Ejemplares similares